Promoter collection, Human HIF1A promoter
Alternative name | U3136-6 |
---|---|
Clone info. | PCR amplified human HIF1A promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 61694082 to 61695550(NC_000014.9); relatively -1431 to +38, where +1 corresponds to 1 nt of NM_001530.4. |
Comment | PCR cloning, forward primer: cccatggttcttttcaagaca; reverse primer: atcctcctgtcccctcagac. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07693.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07693 | pGL4-phHIF1A | DNA solution |
Materials & Methods section:
The pGL4-phHIF1A was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07693). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07693_A4La.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07693_A4Laa.seq ![]() |
---|
>07693_07693_A4La_pGL4-4174F_A04_01.ab1 1 ATGGGTCAGA CATTTCTCTG GCCTACTGGC CGGTACCTGA GCTCGCTAGC CTCGAGGATC 61 CCATGGTTCT TTTCAAGACA TAATACATAT CATTTAGTGT TGTAGATCTG AAAAAACAAA 121 AGTAGCGTGA AGATCAAAAA TTTTCTAAAG AGACGGAGTC TCGCTACGTT CCCTAGGCTG 181 GAACACCCAG GCTTCTCCAG CCTCACACCT CTGAGTAGCT GGAACCACCC TGTCCGCTAA 241 GGTCAATGTT TAATCGTATC TTTGTAGGTC TACTGACCAG TTAAAAAGAG GTGCTGTATA 301 CATTGGTTGT TGTCTTGTCA GAGTTTGATG CTTCTATATA GACCATTGTT TTTACATGCT 361 AATACAATTG AAAGCCACTA CAGATATTTA TATTTACAAC CCAAAGCTAG GTTTTAACAA 421 GAAACTCATA AGGCAAAGGT GAGAAGTAAA ATAATTTAGC GCCAAGTGGA GATATATGTG 481 CAATGCTACT TTGTTGGGCT CAAAACATAT TTTTCTTTTA GAAGACTGAC AGGCTTGAAG 541 TTTATGCCTC CAAAGACAAA AGTGATTACG TTTTGTTTAG TAGCTTGCAA AGTTGCCAAA 601 GGCCATTTTT TCTACTCTTT CCCTGAAATT GGTTTATATG CTTATTAAAG TCATTTATAC 661 CTATTTGCAA ATGCTTAACA TAGTTTCAGA TTTTAAGATT TCCCTGCAAC TTTATTTCCC 721 TTGAAGTTTA CAGCAACAGG AGTTCATTTT TATTTTTAAT TGCATTTATT CAGTAAGTAA 781 ACTCCGCCAC AGAAAAACTT AGTAGACAAG GTGAGTTCCC CTGTGCTCCG TGGCAAAGAG 841 TGCGGTGGGT GACATTGACC CATGGTTAGG TAATCTGGTA AGGAAGACCC CGTTGTAACA 901 CATCTGAGCA ACGAGACCAA AGGAAGGGCT TGCTGCCACG AGGCGAAGTC TGCTTTTTTT 961 GAACAGAGAG CCCAGCAGAG TTGGGCGGCA ATCGTGCCCA GCACTGAGGC CGAGGAGAAG 1021 AGAGCAGGAG CATTACATTA CTGCACCAAG AGTAGGAAAA TATGATGCAT GTTTGGGACC 1081 AGGCAACCGA AATCCCTTCT CAGCAGCGGC TTCCTAAAGG TGGCAACGAC GTTCCTTCGG 1141 AGAAGGCGCA GAAGTTCCCC CAGAGAAACG TCG // |
Primer: pGL4-136R Sequence file: RDB07693_A4Lab.seq ![]() |
>07693_07693_A4La_pGL4-136R_B04_04.ab1 1 GACTATGTTT GGCATCTTCC ATGGTGGCTT TACCAACAGT ACCGGATTGC CAAGCTTGGC 61 CGCCGAGGCC AGATCTTGAT ATCCTCCTGT CCCCTCAGAC GAGGCAGCAC TGTGCACTGA 121 GGAGCTGAGG CAGCGTCAGG GGGCGGGCAA GGGCGGAGGC GCGCTCGGGC GCGCGGGGAG 181 GGGAGAGGGG GCGGGAGCGC GCCCGCTCGC CTGCCCTGGC CGGCGCGCGC TCCCGCAAGC 241 CCGCCTCACC TGAGGTGGAG GCGGGTTCCT CGAGATCCAA TGGCGAGCGA CGCAGGCGGC 301 AAGTCCCCAC CCCAGCCCAA GCCGCTCTCA GCCAATCAGG AGGCGGTCAG CTGAGGCACA 361 GCTGGGACGG GCTGCGACGC TCACGTGCTC GTCTGTGTTT AGCGGCGGAG GAAAGAGAAA 421 GGAGATGGGG GTGCGGCTCA GCCCGAGTCT GGGGACTCTG CGCCTTCTCC GAAGGAAGGC 481 GGTGCCCGGC TTTGGGAGGC GCTGCTGAGA AGGGATTTCG GTTGCCTGGT CCCAAACATG 541 CATCATATTT TCCTACTCTT GGTGCAGTAA TGTAATGCAC CTGCTCTCTT TCTCCTCGGC 601 CTCAGTGCTG GGCACGATTG CCGCCCAACT CTGCTGGGCT CTCTGTTCAA AAAAGCAGAC 661 TTCGCCTCGT GGCAGCAAGC CCTTCCTTTG GTCTCGTTGC TCAGATGTGT TACAACGGGG 721 TCTTTCCTTA CCAGATTACC TAACCATGGG TCAATGTCAC CCACCGCACT CTTTGCCACG 781 GAGCACAGGG GAACTCACCT TGTCTACTAA GTTTTTCTGT GGCGGAGTTT ACTTACTGAA 841 TAAATGCAAT TAAAAATAAA AATGAACTCC TGTTGCTGTA AACTTCAAGG GAAATAAAGT 901 TGCAGGGAAA TCTTAAAATC TGAAACTATG TTAAGCATTT GCAAATAGGT ATAAATGACT 961 TTAATAAGCA TATAAACCCA ATTTCAGGGA AAGAGTAGAA AAAATGGCCC TTTGGCAACT 1021 TTGCCAGCTA CTAAACAAAA CGTAATCACT TTTGTCTTGA GGCATAACTT CAAGCCTGTC 1081 AGGTCTTCTA GAGGAAAAAT ATGTTTTGAG CCACCAAAGG TAGCATTGCA CATATATCTT 1141 CCACCTTGCG CTAAATACTT ACTTCGTCAC GCTTTGGACC TTTATTTGA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Chiba, R., ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation. PLoS One 12 (8): e0183516 (2017). PMID 28837676. [link to RRC of NBRP] |
---|
Featured content